# SELLAS Life Sciences Group, Inc.: Form 8-K, filed Jan 16, 2025

- Company: [SELLAS Life Sciences Group, Inc.](/companies/sls.md) (CIK 1390478)
- Form: 8-K
- Filed: 2025-01-16
- Accepted by EDGAR: Jan 16, 2025, 16:11 ET
- Period: 2025-01-10
- Accession: 0001104659-25-004107
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1390478/000110465925004107/tm253479d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1390478/000110465925004107/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1390478/000110465925004107/tm253479d1_8k.htm

Filed Jan 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-004107. Last ingested by Listed: Nov 10, 2026, 17:29 ET. No prices; not investment advice.